retatrutide glp 1 PDB-101: Molecule of the Month: GLP-1 Receptor Agonists Retatrutide Triple Agonist (GLP-1/GIP/GCG) |

Glucagon receptor stimulation increases hepatic fatty acid oxidation and promotes lipolysis in adipose tissue through GIP receptor activation, creating metabolic conditions that favor fat utilization

Large clinical trials have demonstrated their effectiveness, and they are now increasingly prescribed for diabetes and weight management

Effects of Treatment with Proton Pump Inhibitors in Metabolic Control in Patients with type 2 Diabetes [abstract 2425PO]

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

While increasingly available through clinics and compounding pharmacies, enclomiphene lacks FDA approval, which can affect insurance coverage and availability